Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
2861
PCR reaction system.
Published 2025“…The results showed that: (1) Compared with the CON group, the dressing percentage and eye muscle area in the SBS24 group significantly increased (<i>P</i> < 0.05); (2) Compared with the CON group, the butyrate content and total fatty acid content inthe SBS24 group significantly increased (<i>P</i> < 0.05); (3) Compared with the CON group, the Simpson index of the SBS groups significantly increased (<i>P</i> < 0.05), while the Shannon index of the SBS12, SBS18, and SBS24 groups significantly decreased (<i>P</i> < 0.01). …”
-
2862
Nutritional composition of SBS (DM basis, %).
Published 2025“…The results showed that: (1) Compared with the CON group, the dressing percentage and eye muscle area in the SBS24 group significantly increased (<i>P</i> < 0.05); (2) Compared with the CON group, the butyrate content and total fatty acid content inthe SBS24 group significantly increased (<i>P</i> < 0.05); (3) Compared with the CON group, the Simpson index of the SBS groups significantly increased (<i>P</i> < 0.05), while the Shannon index of the SBS12, SBS18, and SBS24 groups significantly decreased (<i>P</i> < 0.01). …”
-
2863
Risk of bias across 22 included studie.
Published 2024“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
-
2864
An overview of the selection process for studies.
Published 2024“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
-
2865
Characteristics of studies (<i>n</i> = 22).
Published 2024“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
-
2866
-
2867
-
2868
<sup>177</sup>Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy
Published 2025“…However, we observed that the NGR sequence of L6 was gradually rearranged to iso-DGR under alkaline conditions, resulting in decreased stability. …”
-
2869
-
2870
Data file without outliers.
Published 2025“…At follow-up, the increase in KYN and KYN/TRP was related to a decrease in ExCap in CKD 2–3. After adjusting for GFR, increase in KYN/TRP remained an independent significant predictor of a decline in ExCap in CKD 2–3.…”
-
2871
-
2872
-
2873
Characteristics of the population studied.
Published 2024“…In this qualitative study among PrEP users, mostly MSM, we explored perceptions, knowledge, and access barriers. …”
-
2874
-
2875
Overview of the validated interview guide.
Published 2024“…In this qualitative study among PrEP users, mostly MSM, we explored perceptions, knowledge, and access barriers. …”
-
2876
-
2877
-
2878
-
2879
-
2880